HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) All Versions of this Article: ERC-08-0036v1 15/4/1069    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryder, M. Articles by Fagin, J. Search for Related Content PubMed PubMed Citation Articles by Ryder, M. Articles by Fagin, J.

M Ryder, Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, 10021, United States
R Ghossein, Pathology, Memorial Sloan-Kettering Cancer Center, New York, United States
J Ricarte-Filho, Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, United States
J Knauf, Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, United States
J Fagin, Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, United States

Correspondence: Mabel Ryder, Email: ryderm{at}mskcc.org

Abstract

Thyroid cancers are infiltrated with tumor-associated macrophages (TAMs), yet their role in cancer progression is not known. The objectives of this study were to characterize the density of TAMs in well-differentiated (WDTC), poorly-differentiated (PDTC) and anaplastic thyroid cancers (ATC) and to correlate TAM density with clinicopathologic parameters. Immunohistochemistry was performed on tissue microarray sections from WDTC (n=33), PDTC (n=37) and ATC (n=20) using macrophage specific markers. Electronic medical records were used to gather clinical and pathologic data. Follow-up information of PDTC patients was available for 0-12 years. Nine of 33 WDTC (27%), 20/37 PDTC (54%) and 19/20 ATC (95%) had an increased density of CD68+ TAMs (=/>10 per 0.28 mm2) (p = 0.03, WDTC vs. PDTC; p < 0.0001. WDTC vs. ATC; p < 0.002, PDTC vs. ATC). Increased TAMs in PDTC was associated with capsular invasion (p = 0.034), extrathyroidal extension (p = 0.009) and decreased cancer-related survival (p = 0.009) compared to PDTC with a low density of TAMs. In conclusion, the density of TAMs is increased in advanced thyroid cancers. The presence of a high density of TAMs in PDTC correlates with invasion and decreased cancer-related survival. These results suggest that TAMs may facilitate tumor progression. As novel therapies directed against thyroid tumor cell-specific targets are being tested, the potential role of TAMs as potential modulators of the thyroid cancer behavior will need to be considered.

This article has been cited by other articles:

				J. C. Ricarte-Filho, M. Ryder, D. A. Chitale, M. Rivera, A. Heguy, M. Ladanyi, M. Janakiraman, D. Solit, J. A. Knauf, R. M. Tuttle, et al. Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1 Cancer Res., June 1, 2009; 69(11): 4885 - 4893. [Abstract] [Full Text] [PDF]

				R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44. [Abstract] [Full Text] [PDF]